Targovax ASA (GB:0RIS) has released an update.
Circio Holding ASA board member Robert Burns and COO Ola Melin have actively participated in the company’s Rights Issue, subscribing to 50,000 and 40,000 offer shares respectively, priced at NOK 2.50 each. The Rights Issue also involves the allocation of corresponding warrants and is subject to board allocation and issue completion. Circio, a biotech firm, is making strides in RNA therapeutics and cancer vaccines, with multiple clinical trials underway.
For further insights into GB:0RIS stock, check out TipRanks’ Stock Analysis page.
